Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -210,960 | -151,528 | -88,301 | -40,373 | -156,730 |
| Depreciation Amortization | 193 | 139 | 90 | 44 | 126 |
| Accounts receivable | 11,764 | 11,762 | 8,817 | -947 | -11,633 |
| Accounts payable and accrued liabilities | -16,968 | -4,495 | -10,967 | -17,485 | 16,430 |
| Other Working Capital | -10,853 | -6,605 | -14,198 | -33,456 | 15,142 |
| Other Operating Activity | 38,631 | 18,327 | 18,554 | 26,398 | 30,553 |
| Operating Cash Flow | $-188,193 | $-132,400 | $-86,005 | $-65,819 | $-106,112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -197 | -171 | -73 | -42 | -254 |
| Investing Cash Flow | $-197 | $-171 | $-73 | $-42 | $-254 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 200,000 |
| Common Stock Issued | 71,157 | 70,924 | 21 | 21 | N/A |
| Other Financing Activity | -272 | -272 | 0 | 0 | 129 |
| Financing Cash Flow | $70,885 | $70,652 | $21 | $21 | $200,129 |
| Exchange Rate Effect | 220 | 710 | -1,987 | -772 | -92 |
| Beginning Cash Position | 493,817 | 493,817 | 493,817 | 493,817 | 400,146 |
| End Cash Position | 376,532 | 432,608 | 405,773 | 427,205 | 493,817 |
| Net Cash Flow | $-117,285 | $-61,209 | $-88,044 | $-66,612 | $93,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -188,193 | -132,400 | -86,005 | -65,819 | -106,112 |
| Capital Expenditure | -197 | -171 | -73 | -42 | -254 |
| Free Cash Flow | -188,390 | -132,571 | -86,078 | -65,861 | -106,366 |